Literature DB >> 2569216

Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.

S A Parashos1, P Barone, C A Marin, A J Paraschos, V Kapitzoglou-Logothetis, T N Chase.   

Abstract

The effect of chronic D-1 and/or D-2 dopamine receptor blockade on apomorphine-induced behaviors was studied in rats treated for 21 days with the selective D-1 antagonist SCH23390, the predominantly D-2 antagonist haloperidol, and the combination of the two drugs at the same daily doses (0.1 and 1 mg/kg respectively). Apomorphine (0.3 mg/kg) 4 days following the last injection of the drugs increased (49-70%) stereotypic behavior in all animals as compared to saline-treated controls. Although the SCH23390-induced increase was lower than haloperidol-induced supersensitivity, stereotypies after combined administration of both drugs did not differ significantly from either, suggesting that the effects of the two drugs are not additive. Underlying receptor changes and modified D-1/D-2 receptor interactions may account for the participation of both receptor subtypes to the development of neuroleptic-induced dopaminergic supersensitivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569216     DOI: 10.1007/BF00444690

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.

Authors:  P Barone; I Tucci; S A Parashos; T N Chase
Journal:  Eur J Pharmacol       Date:  1988-05-10       Impact factor: 4.432

2.  [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

Authors:  M L Porceddu; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

3.  Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.

Authors:  G Gianutsos; R B Drawbaugh; M D Hynes; H Lal
Journal:  Life Sci       Date:  1974-03-01       Impact factor: 5.037

4.  Neuroleptic and non-neuroleptic catalepsy.

Authors:  B Costall; R J Naylor
Journal:  Arzneimittelforschung       Date:  1973-05

5.  Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; K L Dew; T D Ely; R B Mailman
Journal:  J Chromatogr       Date:  1985-08-09

Review 6.  The classification of dopamine receptors: relationship to radioligand binding.

Authors:  I Creese; D R Sibley; M W Hamblin; S E Leff
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

Review 7.  Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.

Authors:  R J Baldessarini; D Tarsy
Journal:  Int Rev Neurobiol       Date:  1979       Impact factor: 3.230

8.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade.

Authors:  S A Parashos; P Barone; I Tucci; T N Chase
Journal:  Life Sci       Date:  1987-11-16       Impact factor: 5.037

10.  Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

Authors:  E J Hess; L J Albers; H Le; I Creese
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

View more
  2 in total

Review 1.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.

Authors:  C Marin; T M Engber; P Chaudhuri; A Peppe; T N Chase
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.